Peter Attia’s Eulogy • Peptides & Your License • Stem Cell Showdown • EMR Wars • VO₂max Tech
Issue 64: The front page of longevity medicine - curated by doctors, for doctors.
Hey Doc,
It’s 4:52 am in NYC. My family is asleep, and I’m still replaying what happened on stage at the Vibrant Longevity Summit Austin. What would you say if someone read you your own eulogy while you were still alive?
That’s exactly what I did with Peter Attia. The moment I’ll never forget was seeing Peter laugh, reflect, and take in his own eulogy with warmth and humility, with the front row full of Longevity Docs watching.
We went deep on the biomarkers shaping the future of heart health, the interventions he believes hold the most promise, and the framework he uses to protect his emotional health and relationships.
This week reminded me why we built Longevity Docs: to create moments that go beyond science, moments that shape the culture of longevity medicine.
Healthy sunday!
Dr. David Luu
Founder, Longevity Docs
www.longevitydocs.org
In this week newsletter:
Inside Longevity Docs: Keep Your License with Jeff Cohen Esq • CLD October Cohort
Cover Story: Peter Attia’s Eulogy
Buzz in the Chat: EMR • Stem Cells • V02max tech
Research Radar: Multiomics Blueprint • Reproductive Aging Biomarkers
Longevity in the News: Peptide Dealer • World’s Oldest Person Study
Longevity Intelligence: One Medical • Oura • Juisci • Until Labs
Our team is hard at work, and I’m excited to share what’s happening behind the scenes across the Longevity Docs ecosystem.
Mastermind Faculty Updates
Keep Your License: Critical Peptide Regulations Every Physician Must Know
Most conferences sell you peptides. We’re different.
Our mission is to educate doctors so you remain the source of scientific wisdom and medical innovation.
Understanding the science, business, and risks of the peptide economy is crucial to stay relevant when patients arrive with questions or online prescriptions.
Excited to have Jeff Cohen, Esq., the leading authority in healthcare regulation, joining us at the Mastermind to discuss the risks of peptides.
Keep Your License: Everything you need to know: sourcing, consent, FDA letters, 503A/503B, marketing, and malpractice insurance.
Don’t get left behind. Don’t risk your license.
🎓 One day. Physicians only. Don’t miss your chance to join the community shaping the future of evidence-based longevity medicine.
Only 3 Spots Left - Certified Longevity Doctor, October Cohort
We’re selecting just 3 more physicians to join the October cohort. Be part of an exclusive group of 20 doctors learning the 100-hour curriculum from 15 world-class faculty - the first certification in longevity medicine.
Longevity Docs Around the World
Meet Dr. David Luu and team at the following events:
New York · October 4 — Longevity Docs Peptides Mastermind
Riyadh · October 24–26 — Zenos Health Summit
New York · October 30 — Galien Patient Summit
Miami · November 14 — Longevity Docs Table
Vegas · January 6-9 — CES
Each week, I try to explore one idea that could advance longevity medicine and hopefully support physicians in bringing it to life.
I Read Peter Attia His Eulogy
Two days ago, I was on stage with Dr. Peter Attia at the Vibrant Longevity Summit in Austin. I opened with a question: “You’ve said what matters in longevity is the eulogy, not the résumé. What do you mean by that?”
Peter replied: “At your funeral, no one talks about how hard you worked, how much money you made, or how many companies you built…”
I said: “I actually wrote a eulogy for you. Can i read it.”
“ Dear Peter, we’re in the year 2093. You’ve reached 120, just like you predicted. You even won several Centenarian Decathlons, now an Olympic sport thanks to you.
I remember first meeting you in the hallway of a longevity conference in Vegas, back when casinos and drinking were still a thing. Then again in Austin, at Barton Creek, at a startup conference called Vibrant Summit that grew into one of the largest health systems in the world. And yes, this was back when humans still met face to face.
You were the father of Medicine 3.0. Today we’re at Medicine 9.0: nanobots deliver therapies in real time. No doctor needed anymore
Few ever met you in person, but everyone knew your voice. The Drive became one of the greatest archives in longevity medicine. Outlive 7: The Science and Art of Wisdom is sold out everywhere. Early Medical is finally covered by insurance…about time.
Zone 2 Day is a national holiday. Lp(a) testing is mandatory at birth. And David the protein bar company? Somehow became a cod fish farming company. Sorry about that one.
Being your patient was like trying to get on the La Ferrari waitlist: nearly impossible. Yet you gave so much freely: the science, the unsponsored podcasts, the transparency. Some disagreed with you, but no one doubted, the stubborn fairness and the impact you had on so many doctors
Your hugs were never warm: maybe because of those shoulder prosthesis but your voice warmed the world of longevity. You protected your time fiercely, with Nick and Lacey as your guardians. And you showed Jill and the kids your deepest love when you went to the Bridge To Recovery.
And yes, your calcium score Peter always stayed under six. Your uncle Francis would be proud.
So my dear Peter, thank you for your science, your drive, your impact, and above all, your love of longevity.”
We then discussed cardiovascular diseases and precision testing, including ApoB, Lp(a), sterols, SDMA/ADMA, homocysteine, and ceramides (all part of the Vibrant Cardio Zoomer) and how these markers drive heart disease prevention and management.
We finished the 60-minute conversation with a surprise Egg Boxing session. Discover the video👇
Every week, the Longevity Docs WhatsApp group feels like a front-row seat to the future of medicine. Here’s what had doctors buzzing:
EMR Wars: Which systems are actually working for physicians in 2025?
Longevity Docs compared experiences with EMRs like MD-HQ, Elation, Athena, eClinicalWorks, Vibrant, Practice Better, Charm, Modmed, and Practice Fusion. Frustrations centered on cost, clunky UX, and lack of customization. AI scribes are becoming standard: FreedAI, Nabla, Sunoh, and Vibrant’s built-in tools were all discussed.
Key Takeaways for Doctors:
No perfect EMR exists: most systems have trade-offs; lean toward the one that fits your practice model (cash vs insurance, size, specialty).
AI scribes are here to stay: saving time on charting and documentation is now expected, not optional.
Hidden costs matter: watch for nickel-and-diming (texts, e-Rx, % revenue cuts). Factor this into long-term sustainability.
Community feedback is invaluable: peer reviews help avoid costly mistakes when switching systems.
Metabolic Tech: PNOE, VO₂ Master, Cosmed - which devices deliver?
Longevity Docs compared VO₂ Master, PNOE, Calibre, and Cosmed systems for RMR/REE, VO₂max, and substrate utilization testing. Cost, report accuracy, mobility, and reliability were the biggest concerns. Some noted glitches (Cosmed reports not uploading), while others liked PNOE’s mobility despite high costs.
Key Takeaways for Doctors:
PNOE and VO₂ Master are popular but have trade-offs: mobility vs accuracy.
Cosmed is considered industry standard but less user-friendly and glitch-prone.
Cost vs function is a key decision: PNOE/Calibre are expensive; Cosmed is cheaper but clunky.
Future-proofing matters: new devices (e.g., VO₂ Master with CO₂ sensors in 2026) may shift the landscape.
Not All Stem Cells Are Equal: The Fight Over Safety, Science, and Regulation
A complex case of an 18-year-old with escalating autoimmunity sparked debate on MSCs: bone marrow vs umbilical vs amniotic sources. Arguments centered on immune privilege, FDA approvals (BM MS
Cs in GvHD), safety, and GMP standards. Opinions varied, but consensus was that product quality and regulation matter most.
Key Takeaways for Doctors:
Not all MSCs are the same: source, donor quality, and GMP production determine safety and efficacy.
Regulatory clarity is lacking: only bone marrow MSCs are FDA-approved (for GvHD). Everything else is experimental.
Autoimmunity use cases are emerging: early trials show promise in Crohn’s, diabetes, arthritis, but risks remain.
Education needed: call for a dedicated MSC event highlights demand for physician-to-physician clarity.
Join 500+ Longevity Docs Across 50 Countries
Longevity Docs is a highly vetted, invitation-only community for physicians shaping the future of longevity medicine. Apply online and connect 1:1 with our team
Each week, I highlight a few studies that caught our eyes and could shape the future of longevity medicine.
The multiomics blueprint of the individual with the most extreme lifespan
A multiomics deep dive into the world’s oldest living person reveals that her extreme lifespan is accompanied by features like telomere attrition and clonal hematopoiesis, yet she remains largely disease-free. Key protective traits include rare beneficial genetic variants, low inflammatory signatures, a rejuvenated microbiome, and a younger-appearing epigenome. This work identifies promising biomarkers and biological pathways for healthy aging, but broader studies are needed to validate intervention strategies. Cell Reports Medicine
Biomarkers of female reproductive aging in gerotherapeutic clinical trials
Therefore, this article discusses the available (FSH, AMH, Inhibin, antral follicle count) as well as the emerging biomarkers (estradiol, progesterone, LH, Sirtuin- 1, microRNAs, menstrual blood markers, epigenetic markers, ovarian stiffness, vaginal microbiome markers, survey information) of female reproductive aging and a protocol for evaluating the impact of gerotherapeutics in clinical trials. Ageing Research Reviews
The role of plasma exchange in the management of autoimmune disorders
I comb through the mainstream headlines, handpick the most relevant longevity stories.
Everyone has a Chinese peptide dealer now
At one San Francisco company (Superpower), free peptide injections are offered to the whole staff on Fridays. SFStandard
If A.I. Can Diagnose Patients, What Are Doctors For?
Large language models are transforming medicine—but the technology comes with side effects. The New Yorker
Despite the drama and hype from influencers, longevity science is making real progress
Snake oil is getting in the way of truly exciting anti-aging research. StatNews
Scientists Study Genes of Woman Who Was the World’s Oldest Person
Spanish researchers say Maria Branyas Morera, who lived to 117, won a genetic lottery. But experts caution that healthy genes and microbiomes don’t explain longevity on their own. New York Times
Are the Longevity Rules Different for Women?
Women’s longevity basics mirror men’s: exercise, protein, and sleep. Strength training is vital for muscle and bone, alcohol hits harder, and menopause adds unique risks.
Statins, vaccines, and lifestyle remain key tools for healthy aging. NYT
Scientists reverse stroke damage with stem cells (in Mice)
Scientists in Zurich have shown that stem cell transplants can reverse stroke damage by regenerating neurons, restoring motor functions, and even repairing blood vessels. The breakthrough not only healed mice with stroke-related impairments but also suggested that treatments could soon be adapted for humans, marking a hopeful step toward tackling one of the world’s most devastating conditions. ScienceDaily
Every week, I track the biggest moves in longevity: new funding rounds, partnerships, product launches, and key hires.
Amazon’s One Medical introduces dedicated perimenopause and menopause visits
Hundreds of primary care providers have been specially trained to provide comprehensive, personalized care to help patients during this significant yet underserved transition. Amazon
Oura Ring Maker to Become $11 Billion Company With Latest Raise
The Finnish Oura health and fitness ring maker is raising $875 million in a new Series E financing round valuing it around $10.9 billion. BOF
Juisci which revolutionizes how healthcare professionals access scientific knowledge, has raised €5.5M
Founded in 2021 by Robin Roumengas and Dr. David Luu, Juisci is a SaaS platform that uses proprietary AI and a mobile-first approach to democratize access to scientific knowledge. It helps healthcare professionals save time, combat misinformation, and advance medical progress. StartupRise
Until Labs: $58M Series A for Cryopreservation
Cryonics startup Until Labs raised $58M Series A, bringing total funding to over $100M. Founded by Laura Deming & Hunter Davis, the company is tackling transplant bottlenecks by developing tech to preserve organs indefinitely. Longevity Technology
Longevity Docs Peptides Mastermind
New York City | October 4, 2025
10 sessions • 10 faculty • physician-only
Peptides 101 for Longevity Docs — Leonard Pastrana, PharmD
Discover every physician should know from mechanisms to outcomes
Evidence-based Peptides Protocols — Elizabeth Yurth, MD
Get the peptide playbook: inclusion/exclusion, AE triage, results.
Peptides in Practice — Craig Koniver, MD
Results, revenues, and risk management for modern clinics.
The Peptides Library — Neil Paulvin, DO
Every peptide you hear about: evidence, use cases, and the hype to ignore.
Stronger or Sorrier? — Matt Cook, MD
Peptides for pain, performance, injuries, and regeneration.
Skin in the Game — Saranya Wyles, MD, PhD
Explore peptides for skin longevity: which, when, and how to prove they work.
Cardiometabolic Peptides That Work — Abid Husain, MD
What the data says on peptides and prevention of CAD, diabetes, and stroke.
Gut Feelings — Cynthia Keller, MD
Evidence-based protocols for motility and microbiome health
Keep Your License — Jeff Cohen, Esq
Everything you need to know: sourcing, consent, FDA letters, 503A/503B, marketing, malpractice insurance
The Debate: Click, Ship… or Clinic?
The ethics and compliance of remote peptide programs: 503A scripts, 503B office use, and branded alternatives.
Your fastest path to peptide mastery in longevity medicine.
Longevity Docs Summit Cannes
Cannes, France | June 10-11, 2026
Conferences Calendar
Longevity Docs Peptides Mastermind: New York, October 4
Health Optimization Medicine Symposium: Boulder, October 17-18
Zenos Health Summit: Riyadh, October 23-25, 2025
Longevity Clinic Roundtable: Novato, December 6-8, 2025
A4M: Las Vegas, December 12-13
Hormones Mastermind Replay
For the first time, get full online access to the entire event:
✔ 10 expert-led modules
✔ Real-world protocols and case studies
✔ On-demand viewing, anytime, anywhere
No fluff, no travel: just pure, actionable hormone and longevity education.
Replay Pass: $295
Why every doctor should be a longevity doctor.
The Movement
Longevity Docs is the world’s leading collective of physicians advancing longevity medicine through education, clinical research, advisory, and exclusive experiences. With over 400 members in 50+ countries, we’re building the global infrastructure for evidence-based, personalized longevity care.
Why “Longevity Docs”?
Because we believe longevity is not a specialty — it’s a human right.
The future of medicine is proactive, not reactive. It's interdisciplinary, not isolated. It’s collaborative, data-driven, and deeply human. And it starts with us — the physicians who dare to redefine what care looks like across the decades of a patient’s life.
“Longevity Docs” isn’t just a name. It’s a statement of purpose.
Our Ecosystem
Physician Network
A trusted global collective of longevity-focused doctors exchanging protocols, referrals, and real-world clinical outcomes.Education & Certification
Earn your Certified Longevity Physician™ designation through our advanced curriculum, live masterclasses, and continuous learning tracks.Decentralized Research
Lead or participate in multicenter clinical trials and patient registries, accelerating evidence generation for healthspan optimization.Strategic Advisory
We partner with vetted longevity companies, life-science, tech, and clinics to help them grow.Global Events & Experiences
Access exclusive gatherings like the NYC Mastermind and the Cannes Longevity Summit & Awards
Who It’s For
Doctors → Join the club, get certified, grow your practice
Health Systems → Implement clinical longevity programs
Brands & Startups → Validate products, find advisors, run trials
Investors → Gain early access to insights, doctors, and deal flow
We’re not just witnessing the transformation of longevity medicine we’re building it. Together.
Subscribe to the Longevity Docs Newsletter
Stay connected with the backstage of the Longevity Docs community, a network of over 500 physicians spanning 50 countries, united in our mission to democratize longevity medicine. Explore the latest in evidence-based longevity care, gain exclusive access to physician insights, and join us in shaping the future of this transformative field.
Newsletter Disclaimer: